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Abstract
 
To define the phenotype and T cell receptor (TCR) repertoire of CD1d-dependent T cells, we
compared the populations of T cells that persisted in major histocompatibility complex (MHC)-
deficient mice, which lack mainstream T cells, with those from MHC/CD1d doubly deficient
mice, which lack both mainstream and CD1d-dependent T cells. Surprisingly, up to 80% of the
CD1d-dependent T cells were stained by tetramers of CD1d/
 
a
 
-galactosylceramide, which spe-
cifically identify the previously described CD1d autoreactive V
 
a
 
14-J
 
a
 
18/V
 
b
 
8 natural killer
(NK) T cells. Furthermore, zooming in on the CD1d-dependent non-V
 
a
 
14 T cells, we found
that, like V
 
a
 
14 NK T cells, they mainly expressed recurrent, CD1d autoreactive TCR families
and had a natural memory phenotype. Thus, CD1d-restricted T cells differ profoundly from
MHC-peptide–specific T cells by their predominant use of autoreactive and semiinvariant,
rather than naive and diverse, TCRs. They more closely resemble other lineages of innate lym-
phocytes such as B-1 B cells, 
 
gd
 
 T cells, and NK cells, which express invariant or semiinvariant
autoreactive receptors. Finally, we demonstrate that the MHC-restricted TCR repertoire is es-
sentially non–cross-reactive to CD1d. Altogether, these findings imply that lipid recognition by
CD1d-restricted T cells may have largely evolved as an innate rather than an adaptive arm of
the mouse immune system.
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Introduction
 
The MHC and the CD1 gene families diverged several
hundred million years ago from the duplication of an an-
cestor locus (1). The CD1 locus of mammals includes up to
five distinct isotypes encoding 
 
b
 
2-microglobulin–associ-
ated molecules that, based on sequence homology, segre-
gate into two groups. Group I contains CD1a, b, c, and e,
and group II contains CD1d (2). In contrast to MHC, CD1
molecules are not polymorphic, and they present lipids
rather than peptides to T cells (3, 4). These two features
have raised the prospect that CD1 might serve as the basis
for population-wide vaccines directed against conserved
microbial and tumor-specific glycolipids. However, the di-
versity of the CD1-restricted TCR repertoire is still un-
known, as is the extent to which it might be able to gener-
ate effective primary and secondary adaptive immune
responses against a broad range of antigens.
 
CD1-restricted T cells differ in several interesting ways
 
from MHC-restricted T cells. For example, they include
an inordinate proportion of double negative (DN)
 
1
 
CD4
 
2
 
CD8
 
2
 
 
 
ab
 
 T cells (3, 5), a phenotype also associated
with some unusual autoreactive, MHC-restricted T cells
(6–8). They also include prominent T cell subsets expressing
characteristics of innate rather than adaptive antigen recog-
nition such as the CD1d autoreactive V
 
a
 
14 NKT cells and
the CD1c autoreactive V
 
d
 
1 T cells. V
 
a
 
14 NKT cells ex-
press a TCR repertoire made of an invariant V
 
a
 
14-J
 
a
 
18
chain (V
 
a
 
24-J
 
a
 
18 in humans) mainly associated with the
variable V
 
b
 
8 chains (V
 
b
 
11 in humans; reference 9) and
 
uniformly recognize the glycolipid 
 
a
 
-galactosylceramide
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Abbreviations used in this paper:
 
 
 
a
 
GalCer, 
 
a
 
-galactosylceramide; DN, dou-
ble negative; TAP, transporter associated with antigen processing. 
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(
 
a
 
GalCer) at picomolar concentrations (4). They also ex-
press several receptors associated with the NK lineage. De-
spite their limited TCR repertoire, V
 
a
 
14 NKT cells consti-
tute a disproportionate fraction of the mature T cell
population of the adult spleen (2%), thymus (10%), bone
marrow (20%), and liver (30%). V
 
d
 
1 
 
gd
 
 T cells constitute a
major population of human intraepithelial intestinal lym-
phocytes and are considered to be part of the innate rather
than adaptive immune system (10). These prominent V
 
a
 
14
and V
 
d
 
1 CD1-restricted subsets seem to obey a logic that
differs markedly from adaptive lymphocytes but closely re-
sembles other “innate” lymphocytes, such as B-1 B cells, 
 
gd
 
T cells, and NK cells, which express invariant or semiinvari-
ant antigen receptors and survey self-antigens or promiscu-
ous (self plus foreign) antigens that are induced or exposed
in conditions of infection, stress, or transformation (11–15).
However, there are indications that the CD1 system may
have taken up a more recent evolutionary function of pre-
senting a variety of lipid antigens to the adaptive immune
system. Recent studies have shown that distinct mycobac-
terial lipid antigens could be recognized by in vitro–derived
CD1-restricted T cell lines (for a review, see reference 3).
In addition, patients recently infected with 
 
Mycobacterium
tuberculosis
 
 exhibited detectable CD1c-restricted T cell
responses to a semisynthetic isoprenoid glycolipid resem-
bling natural mycobacterial antigens (16). Other studies
have also suggested some diversity in both TCR repertoire
and antigenic specificities (17–23).
The coexistence of innate and adaptive TCR recogni-
tion would be a unique and fascinating aspect of the CD1
system, likely to have important evolutionary implications
for the protective value of lipid, as opposed to peptide, rec-
ognition. Therefore, we set out to define the respective
sizes of the adaptive and innate T cell populations associ-
ated with CD1d, the only CD1 isotype expressed in mice,
and the one shared by most, though perhaps not all (24),
mammals thus far examined. To search for a diverse, adap-
tive population of CD1d-restricted T cells, we quantita-
tively examined the contribution of CD1d to the selection
of CD4, CD8, and DN 
 
ab
 
 T cells by comparing the size
and composition of the residual T cell populations in mice
deficient for MHC (which lack mainstream 
 
ab
 
 T cells)
versus mice doubly deficient for MHC and CD1d (which
lack both the mainstream T cells and the CD1d-dependent
T cells). By using fluorescent tetramers of CD1d1/
 
a
 
GalCer
complexes to specifically identify V
 
a
 
14 T cells, we were
able to focus on the non–V
 
a
 
14-based T cell population,
determine its size and phenotype, and analyze its TCR rep-
ertoire. Further, we explored the possibility that classical
MHC molecules might select T cells able to cross-react
with CD1d that would contribute to the CD1d-restricted
repertoire.
Our results indicate that the mouse CD1d-restricted
TCR repertoire is limited in both size and diversity. It is
dominated by cells bearing a few recurrent semiinvariant
TCRs that exhibit the hallmarks of self-antigen–driven se-
lection and the same “natural memory” NKT phenotype as
V
 
a
 
14 NKT cells. These surprising findings imply that rec-
 
ognition of lipid antigens by mouse CD1d-restricted T
cells largely evolved in the context of innate rather than
adaptive immunity.
 
Materials and Methods
 
Mice.
 
C57BL/6 mice were obtained from Taconic Farms.
Mice deficient in K
 
b
 
D
 
b
 
 or transporter associated with antigen
presentation (TAP)-1 (referred to as MHC class I deficient), I-A
 
b
 
(MHC class II deficient), CD1d1, or CD1d1/CD1d2 (CD1d de-
ficient), and their crosses were used after 7–13 backcrosses to
C57BL/6 (25). All the results reported in this study were derived
from comparative analysis of littermates expressing 
 
2
 
/
 
2
 
 versus
 
1
 
/
 
2
 
 or 
 
1
 
/
 
1
 
 genotypes. All mice were raised in a specific
pathogen-free barrier environment at Princeton University, ac-
cording to institutional animal care and use guidelines.
 
Flow Cytometry Studies and Monoclonal Antibodies.
 
To obtain
liver or lung lymphocytes, the organs were first cut into small
pieces and passed through a nylon mesh in PBS/1% BSA, then
the cell suspension was centrifuged over a layer of Ficoll-Paque™
(Amersham Pharmacia Biotech) and the lymphocytes were col-
lected at the interface between Ficoll and PBS-BSA. Fluoro-
chrome or biotin-conjugated anti-pan TCR-
 
b
 
, V
 
b
 
8.1/8.2, V
 
b
 
7,
V
 
b
 
2, V
 
b
 
6, V
 
a
 
3.2, CD44, CD69, CD122, CD4, CD8, CD5,
NK1.1, and heat stable antigen were obtained from BD Phar-
Mingen, as well as streptavidin-Cychrome, -allophycocyanin, or
-PE. Anti-V
 
a
 
8 monoclonal antibodies including KT 50, KT 65,
and B21.14 (26, 27) were obtained from BD PharMingen and
through Dr. B.J. Fowlkes (National Institutes of Health, Be-
thesda, MD). Samples were analyzed using a FACS Vantage™
(Becton Dickinson) equipped with argon and dye lasers, or a
four-color FACSort™ equipped with argon and 635-nm diode
lasers (Becton Dickinson), and CELLQuest™ software.
 
CD1d1/
 
a
 
GalCer Tetramers.
 
Recombinant soluble CD1d1
molecules with a biotinylation sequence were produced in a fly
expression system, purified, and biotinylated as reported previ-
ously (28). Soluble biotinylated recombinant CD1d1 molecules
were incubated for 18 h with a 2 
 
m
 
M stock solution of 
 
a
 
GalCer
in 0.5% Tween 20, and free 
 
a
 
GalCer was removed by centrifuga-
tion dialysis in a Microcon YM-30 tube (Millipore). Tetramers
were generated by mixing 
 
a
 
GalCer-loaded monomers with fluo-
rochrome-labeled streptavidin (streptavidin-PE, streptavidin-allo-
phycocyanin, or streptavidin-Cychrome from BD PharMingen at
5:1) without further separation by gel filtration. Staining was per-
formed by incubating cells on ice for 3 h with tetramers at a con-
centration equivalent to 3–5 
 
m
 
g/ml of CD1d1.
 
Killing Assay.
 
C57BL/6.CD1d
 
2
 
/
 
2
 
 female mice were injected
intraperitoneally with 3
 
 3 
 
10
 
6
 
 spleen cells from male or female
C57BL/6 or C57BL/6.CD1d
 
2
 
/
 
2
 
 mice. 2 wk later, spleen cells
were cultured with irradiated (3,000 rads) male C57BL/6 spleno-
cytes for 5 d in culture medium supplemented with 10 U/ml IL-2
before assay against tritiated thymidine-labeled LPS blasts, as de-
scribed (JAM test;
 
 
 
reference
 
 
 
29).
 
T Cell Hybridoma Production and In Vitro Stimulation.
 
T cell
hybridomas were obtained as described previously, by fusion
with BW5147
 
ab
 
2 
 
of sorted NK1.1
 
1
 
 or NK1.1
 
2 
 
MHC class II–
deficient CD4 splenocytes that had been stimulated for 4–5 d
with anti-CD3 and a mixture of IL-7 and IL-2 (23, 30). To de-
tect CD1d autoreactivity, 5
 
 3 
 
10
 
4
 
 hybridoma cells were mixed in
a 96-well plate with 5
 
 3 
 
10
 
4
 
 mouse CD1d transfectants (rat baso-
philic leukemia mast cells and/or mouse C57SV fibroblasts, as
described) or with 5
 
 3 
 
10
 
5
 
 cells of a 1:1 mixture of splenocytes 
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and thymocytes, using as culture medium a 1:1 mixture of EHAA
and RPMI 1640 (Biofluids) supplemented with 10% FCS, 5
 
 3
 
10
 
2
 
5
 
 M 2 ME, penicillin-streptomycin-gentamycin, and glutamine.
Supernatants were harvested after 18–24 h to measure IL-2 re-
lease using CTLL cells as described. The IL-2 released by CD1d
autoreactive hybrids in the presence of control untransfected cell
lines or CD1d-deficient thymocytes/splenocytes was undetect-
able or at least five times lower than in the presence of CD1d-
expressing cells.
 
TCR Gene Sequencing.
 
Reverse transcription PCR, primers,
and methods were as described previously (23, 31). TCR 
 
a
 
 and
 
b
 
 chain nomenclature is according to the new World Health Or-
ganization-International Union of Immunological Societies
(IUIS) nomenclature (32).
 
Results
 
The Size and Phenotype of the CD1d-dependent T Cell Pop-
ulation.
 
To improve our ability to identify CD1d-depen-
dent T cells, we studied MHC-deficient mice, where the
major “mainstream” population of MHC-restricted T cells
is absent. We compared the size and phenotype of the T
cell populations present in various lymphoid and nonlym-
phoid tissues of MHC only and MHC/CD1d doubly defi-
cient mice. To minimize individual variations, we always
compared littermates and usually cagemates derived from
CD1d
 
1
 
/
 
2
 
 intercrosses or crosses between CD1d
 
2
 
/
 
2
 
 and
CD1d
 
1
 
/
 
2
 
 mice. In addition, all strains of mice deficient in
MHC class II (I-A
 
b
 
), MHC class I (K
 
b
 
D
 
b
 
 or TAP), or
CD1d were on the same C57BL/6 background.
We studied NK1.1-positive and -negative 
 
ab
 
 T cells
separately, as NK1.1 is prominently expressed by some but
not all CD1d-restricted T cells. Representative examples of
FACS
 
®
 
 dot plots displaying the CD4/CD8 versus NK1.1
profiles of TCR-
 
a/b1 gated splenocytes are shown in Fig.
1 A for both the MHC class II–deficient and the MHC
class I–deficient backgrounds. In addition, results from sev-
eral experiments were compiled. The bar graphs in Fig. 1 A
show the average values of the ratio of the cell number in
the CD1d-deficient over that in the CD1d-sufficient back-
ground for several pairs of littermates (measured for 5–14
pairs of littermates per point) in the thymus, spleen, liver,
bone marrow, and Peyer’s patches.
As expected, in the MHC class II–deficient background,
where the mainstream CD4 ab T cell population is absent,
a marked reduction of up to 70–80% of the CD41NK1.11
population, which is mainly composed of Va14 T cells,
was observed in the absence of CD1d. CD41 NK1.12 cells
in the spleen and the bone marrow of MHC class II–defi-
cient mice also exhibited a 30–40% average decrease in the
absence of CD1d, suggesting the presence of a CD1d-
dependent subset among these cells, but in other tissues
they were largely unaffected. Other populations in either
the MHC class I– or MHC class II–deficient backgrounds
were largely unaffected except for the CD42CD82 DN
cells, where a clear reduction was seen among the NK1.11
cells of the thymus in CD1d-deficient mice. For the few
residual CD8 cells in the MHC class I–deficient (TAP- or
KbDb-deficient) backgrounds, which are very rare and
mostly NK1.12, no change in frequency was found in the
absence of CD1d.
Thus, the CD1d-dependent population uncovered by
this analysis is predominantly composed of cells which
seem to qualitatively and quantitatively correspond to the
Va14 NK1.11 T cells that were characterized previously
Figure 1. Residual ab T cell subsets in MHC-versus MHC/CD1d–deficient mice. (A) NK1.11 and NK1.12 subsets. FACS® dot plots represent
the TCR-b1 gated splenocytes from MHC class II– and MHC class I–deficient mice stained with antibodies against NK1.1, CD4, and/or CD8. In
the bar graphs, bars represent the average ratio of the numbers of each cell type in CD1d2/2 mice versus CD1d1/2 littermates (5–14 littermate pairs
per data point). MHC class I2/2 mice were either KbDb2/2 or TAP2/2; results with KbDb2/2 mice (shown in the FACS® dot plots) and TAP2/2 mice
(summarized in the bar graphs) were similar. Error bars are not shown for graphic clarity. ND, not detected (frequency ,0.05%). *Statistically signifi-
cant (P , 0.05). (B) CD1d/aGalCer1 and CD1d/aGalCer2 subsets. The FACS® dot plots show the CD4 and CD1d/aGalCer tetramer profiles of
TCR-b1 gated cells from MHC class II2/2CD1d1/2 and MHC class II2/2CD1d2/2 littermates, as indicated. The bar graphs represent the average ra-
tio of the numbers of CD1d/aGalCer2 cells in CD1d2/2 mice versus CD1d1/2 littermates (four to eight littermate pairs per data point).896 The CD1d-restricted TCR Repertoire
(9, 33, 34). A population of NK1.12CD4 T cells in the
spleen and the bone marrow also seemed to be CD1d re-
stricted, but their frequency was less than that of the ca-
nonical NK1.11 Va14 T cells in these tissues. We studied
these cells in greater detail (see below). However, it should
be noted that z50% of all CD41TCR-a/b1 MHC class
II–deficient splenocytes appeared to be CD1d independent.
Their specificity and function remain to be determined. Fi-
nally, despite the fact that CD8 seems to be a coreceptor
for CD1d (35–37), the study did not detect a sizable popu-
lation of CD1d-dependent CD8 T cells.
CD1d/aGalCer1 T Cells Account for the Great Majority of
CD1d-dependent T Cells. In both mice and humans,
aGalCer is uniformly and exclusively recognized by cells
expressing the canonical mouse Va14 or human Va24
TCRs. Using fluorescent CD1d/aGalCer tetramer stain-
ing, we and others recently showed that a fraction of Va14
T cells did not express NK1.1 and conversely, that a frac-
tion of NK1.11 T cells did not express the canonical Va14
TCR (28, 38, 39). Thus, to refine our in vivo analysis of
the CD1d-dependent T cell population, we reexamined
the population of CD4 T cells in MHC class II–deficient
mice, using CD1d/aGalCer tetramers to specifically deter-
mine the contribution of Va14 T cells, independently of
their NK1.1-positive or -negative cell surface phenotype.
We stained cells from various tissues of CD1d-sufficient or
-deficient, MHC class II–deficient mice with anti-CD4,
anti–TCR-b, and tetramers. As expected, there were no
CD41 tetramer-positive cells in the TCR-b1 population of
CD1d-deficient mice. However, the frequencies of CD41
tetramer-negative cells were not detectably affected (Fig. 1
B). Thus, for example, the 6.1% of the total splenic ab T
cells that expressed the CD41 tetramer-positive phenotype
in MHC class II–deficient mice disappeared in the absence
of CD1d (0.2%), whereas the 8.4% that were CD41 tet-
ramer-negative persisted (9.1%). A similar conclusion is
reached after examination of the bar graphs in Fig. 1 B
showing the average values of the ratio of the cell numbers
in the CD1d-deficient over that in the CD1d-sufficient
background for several pairs of littermates (measured for
four to eight pairs of littermates per point) in the thymus,
spleen, liver, and bone marrow.
Thus, after excluding the conventional MHC-restricted
T cells by using MHC-deficient mice, and the canonical
Va14 T cells by staining with CD1d/aGalCer tetramers,
our examination failed to find evidence for a sizable popu-
lation of CD1d-dependent TCR-a/b1 T cells that did not
use the Va14 TCR. This result implies that the minor set
of CD1d-dependent, NK1.12CD4 T cells we had seen in
the spleen and bone marrow is composed of Va14 T cells
and is in agreement with our recent finding that a subset of
Va14 T cells in wild-type C57BL/6 mice do not express
NK1.1. These data, together with studies of other tissues
such as the lung, gut, lymph nodes, and blood, where
CD1d-dependent T cells are very rare (data not shown),
indicate that the non-Va14 CD1d-restricted T cells must
be extremely rare.
The Non-Va14, CD1d-dependent TCR Repertoire. In
apparent contradiction to the above in vivo findings, we
and others have reported previously several examples of in
vitro–derived CD41 CD1d autoreactive hybridomas or
clones that expressed non-Va14 TCRs (17, 22, 23, 30). To
reexamine the frequency and the TCR repertoire of these
cells, we undertook a large-scale, systematic study of T cell
hybridomas derived from short-term TCR-b–activated
CD41  NK1.1-positive or -negative splenocytes from
MHC class II–deficient mice. We measured the frequency
of hybridomas expressing the canonical Va14-Ja18 TCR
a chain by PCR. We also tested for CD1d autoreactivity
by measuring the IL-2 released after exposure to a CD1d-
expressing thymic/splenic cell mixture or to various CD1d
transfected cell lines versus CD1d-deficient thymic/splenic
cells or untransfected cell lines. Table I shows that out of
.400 hybridomas examined, 82% of the hybrids derived
from the NK1.11 and 33% of those derived from the
NK1.12 cells expressed the canonical Va14 TCR. Whether
Table I. Frequency of CD4 Hybridomas Expressing CD1d-specific TCRs
NK1.1-negative* NK1.1-positive‡
Autoreactive Nonautoreactive§ Total Autoreactive Nonautoreactive Total
%%
Va14-Ja18 10 23 33 29 53 82
Va3.2-Ja9 1.5 1.5 3  4 3 7
Va84N D i ND 0.5 ND ND
Others 4 ND ND 2 ND ND
*151 hybridomas from two separate fusions of CD41NK1.12 MHC class II2/2 splenocytes.
‡276 hybridomas from two separate fusions of CD41NK1.11 MHC class II2/2 splenocytes.
§Nonovertly autoreactive. As discussed in the text, only a fraction of CD1d autoreactive T cells are detected by the in vitro CD1d stimulation assay,
in part because some hybridomas are poor IL-2 producers.
iIn the absence of a canonical sequence (as in Va14-Ja18 or Va3.2-Ja9) or an overt autoreactivity to CD1d, it was not possible to determine the
frequency of these CD1d-restricted TCRs.897 Park et al.
originating from the NK1.1-positive or -negative cells,
one third of these Va14 hybrids expressed overt autoreac-
tivity to CD1d. It is likely that the frequency of autoreac-
tivity is substantially higher than one third because many
hybridomas are intrinsically low IL-2 producers and the re-
sponse to CD1d-expressing cells is only a fraction of their
response to anti-CD3 stimulation (data not shown). Some
other hybridomas did not express Va14, yet were also
CD1d autoreactive. Collectively, they represented 6.5 and
9.5% of the hybrids in the panels derived from the NK1.1-
positive and -negative CD4 cells, respectively.
Then we analyzed the TCR a and b chains of the non-
Va14 hybridomas that were CD1d autoreactive. While
most used Vb8 chains with diverse CDR3 junction se-
quences and lengths (data not shown), a recurrent usage of
a few Va chains was observed in a disproportionately large
fraction.
A Va3.2-Ja9 rearrangement was repeatedly found in
several independent fusions. It was also expressed by the
hybridoma 431.A11, obtained in a previously published fu-
sion experiment (referred to as Va3.2-Ja8 based on the
previous TCR gene nomenclature). From the analysis of
unrelated Va3.2-Ja9 clones, represented in Table II, a ca-
nonical, quasiinvariant amino acid junction appears to be
recurrently used. Based on this canonical sequence, addi-
tional Va3.2-Ja91 clones could be identified by systematic
reverse transcription PCR screening of the rest of the hy-
bridomas that were not overtly CD1d autoreactive (z55%
of Va3.2-Ja91 hybridomas did not exhibit overt autoreac-
tivity to CD1d, some of which may be low IL-2 producers
that escaped detection by the in vitro assay). Interestingly,
in contrast with the Va14-Ja18 sequence, which is germ-
line encoded, at least two or three nucleotide substitutions
were almost systematically present in the Va3.2-Ja9 junc-
tion, introducing, in 11/14 sequences, an arginine or a
Table II. Nucleotide and Predicted Amino Acid Sequences of the Va3-Ja9 Junctions of 14 T Cell Hybridomas Derived from CD41TCR-a/b1 
Splenocytes of MHC Class II2/2 Mice
Va chain Vb chain
Va3 germline: TGT GCT GTG AGC A
AGC AAC ATG GGC TAC Ja9 germline
Cys Ala Val
93
Lys
94
Gly Asn Met Gly Tyr
431.A11* TGT GCT GTG Aag gGC AAC ATG GGC TAC Vb8.2Jb2.4
S2M1* Vb8.2Jb2.2
F3F11.352* Vb8
Lys Gly
S2M2* ... ... ... Aaa gGC ... ... ... ... Vb8.1Jb2.3
Arg Gly
SPS3.3* ... ... ... Aga gGC ... ... ... ... Vb5
S2M15* ND
Arg Gly
DPS1.1* ... ... ... Agg gGC ... ... ... ... Vb8
32A11.209 Vb8
SPS5.2 Vb8
Arg Gly
31F8.268* ... ... ... cgg gGC ... ... ... ... Vb8
Arg Phe
F5G7.370 ... ... ... cgg ttc ... ... ... ... Vb8
Ser Gly
F3B4.342 ... ... ... AGC gGC ... ... ... ,,, Vb8
Ser
31F1.264* ... ... ... AGC ... ... ... Vb8
SPS8.15 ND
Nucleotide additions are in bold, lowercase letters.
*T cell hybridoma is CD1d autoreactive.
Figure 2. CD1d-dependent Va3.2/Vb8 T cells. Liver lymphocytes
from a pair of MHC class II–deficient and MHC class II/CD1d doubly
deficient littermates were four-color stained with CD1d/aGalCer tet-
ramers and anti-CD4, Va3.2, and Vb8. Right panels are gated from
CD41CD1d/aGalCer2 cells as indicated.898 The CD1d-restricted TCR Repertoire
Table III. Frequency of Va3.21/Vb81CD41 T Cells in MHC Class II2/2CD1d1/2 and MHC Class II2/2CD1d2/2 Mice
Va3.21/Vb81 Va3.21Vb82
Tissue Mice MHC class II2/2CD1d1/2  MHC class II2/2CD1d2/2 MHC class II2/2CD1d1/2 MHC class II2/2CD1d2/2
Spleen 8 2.67 (1.01) 1.43 (0.11) 2.41 (0.18) 2.13 (0.48)
Liver 5 4.71 (2.13) 1.31 (0.41) 2.39 (0.42) 2.84 (0.421)
Data show percentage of CD1d/aGalCer tetramer-negative CD41 T cells.
Table IV. Nucleotide and Predicted Amino Acid Sequences of the Va8-Ja Junctions of Nine CD1d Autoreactive T Cell Hybridomas Derived 
from CD41TCR-a/b1 Splenocytes of MHC Class II2/2 Mice
Va chain Vb chain
Va8 germline: TGT GCT TTG AGT GA Ala Ser Leu Gly
T GAA CTG GCC AGT TTG GGG Ja24 germline
91 92 93 94
Cys Ala Pro Arg Thr
TBA7 TGT GCT ccc cga act ... ... ... ... Vb8.2Jb2.6
Met Thr Thr
S2M6 ... ... atg aca act ... ... ... ... Vb8.2Jb2.1
Gln Gly Gly Arg
CC TAC CAG GGA GGC AGA Ja15 germline
Asp Gly
SPS1.1 ... ... ... ... GAt ggg ... ... ... ... ND
Arg Gly Ser Ala Leu Gly
TA GAT AGA GGT TCA GCC TTA GGG Ja18 germline
Gly
S2M9 ... ... ... ... Ggg ... ... ... ... ... ... Vb8.2Jb2.1
CA TCT TCT GGC AGC TGG Ja22 germline
Arg Gly
SAA8 ... ... cct cta ... ... ... ... ... Vb2Jb2.1
Asn Asn Tyr Ala Gln
GA AAT AAC TAT GCC CAG Ja26 germline
Gly Arg
SPS10.20 ... ... ... Ggg aGA ... ... ... ... ... Vb8
Asn Thr Asn Thr Gly
T AAC ACC AAT ACA GGC Ja27 germline
Asp Leu Pro
P17 ... ... ... ... GAt ctc ccC ... ... ... ... ... Vb14
Ser Ser Asn Thr Asn
TCT TCC AAT ACC AAC Ja34 germline
Ser Pro
SPS1.20 ... ... Tcc cCT ... ... ... ... Vb8
Ala Asn Tyr Gly Asn Glu
GCC AAC TAT GGA AAT GAG Ja48 germline
Glu Trp Asp
SPS1.18 ... ... ... ... GAa tgg gAT ... ... ... Vb5
Nucleotide additions are in bold, lowercase letters.899 Park et al.
lysine in position 94 and a glycine in position 95. Together
with the fixed amino acid length of the junctions, these
substitutions are characteristic of an antigen-driven selec-
tion process. In addition, the requirement for nucleotide
substitution most likely explains why the Va3.2-Ja9/Vb8
cells are less frequent than the Va14-Ja18/Vb8 cells. Inter-
estingly, like Va14 T cells, Va3.2-Ja9/Vb8 cells were
found in both the NK1.1-negative and -positive compart-
ments (3 and 7%, respectively; Table I), whether or not
they were scored as overtly autoreactive to CD1d in the in
vitro culture assay.
Because antibodies against both the Va3.2 and Vb8
gene products are available, we performed a flow cytomet-
ric analysis of these cells among MHC class II–deficient
liver and spleen lymphocytes. By four-color analysis, gating
on the residual CD41 tetramer-negative lymphocytes, we
measured an average frequency of 4.7% Va3.2/Vb8 cells
in the liver and 2.7% in the spleen of a total of five to eight
mice (Fig. 2, and Table III). The Va3.2/non-Vb8 cells
represented only 2.4% on average of the cells in these tis-
sues, indicating a bias towards Vb8 expression (53–66%)
among the Va3.2 cells. In MHC class II/CD1d doubly de-
ficient littermates, the frequency of Va3.2/Vb81 cells de-
creased 2–3.6-fold, while the frequency of Va3.2/non-
Vb8 cells was unchanged, confirming the CD1d restriction
of the majority of the Va3.2/Vb8 population. Thus, we
estimate that z2% of the total residual CD4 splenocytes in
MHC class II–deficient mice express the CD1d autoreac-
tive Va3.2-Ja9/Vb8 TCR. This is much less than the
z40% of residual CD4 cells that are Va14 T cells (Fig. 1
B) and is in good agreement with the hybridoma studies,
supporting the notion that the hybridoma panels did not
distort in major ways the TCR repertoire of MHC class II–
deficient CD4 cells.
Another TCR a chain, Va8, also in conjunction with
Vb8, was also disproportionately used by CD1d reactive
hybridomas (Table I). Different Ja segments were used for
each clone and nongermline elements were systematically
introduced (Table IV). Although the length of these junc-
tions was usually restricted to 9–10 amino acids, there was
no obvious conserved motif among them. In contrast, we
made the surprising observation that none of our nine in-
dependent CD1d autoreactive Va8 clones could be stained
with any of the three available anti-Va8 antibodies KT50,
KT65, and B21.14 (data not shown), suggesting the use of
a restricted subset of Va8 genes. Indeed, further analysis of
whole length Va8 sequences showed that all the Va8 genes
belonged to the Va8S3, Va8S5, Va8S8, and Va8S15 sub-
families, which differ from other mouse Va8S6, Va8S7,
and Va8S9 genes by several amino acid changes in both the
CDR1 and CDR2 regions (32). Thus, reactivity against
CD1d seems to require a particular motif in a CDR loop of
Va8 (which cannot be deduced from the simple inspection
of sequences [data not shown]) that is also the region tar-
geted by the three anti-Va8 monoclonal antibodies. CD1d
autoreactive Va8 cells accounted for 4% of hybridomas
originating from NK1.12 and 0.5% of those originating
from NK1.11 CD4 cells (Table I). Their frequency may be
underestimated because, like a fraction of Va14 and Va3.2
T cells, some of the CD1d-specific Va8 cells may not ex-
hibit overt autoreactivity to CD1d in our in vitro cytokine
release assay and because there is no Va-specific reagent to
stain them in vivo. Conversely, the fact that these autoreac-
tive receptors could not be found in a panel of control hy-
bridomas derived from MHC class II/CD1d doubly defi-
cient CD4 splenocytes emphasizes that they are authentic
CD1d-restricted TCRs.
Finally, some autoreactive hybridomas expressed neither
a Va3.2-Ja9 nor a Va8 TCR a chain (Table V). Collec-
tively, their frequency was less than the combined fre-
quency of the Va3.2-Ja9 and Va8 cells (see Table I). It is
possible that larger studies would also reveal recurrent
TCR usage among these cells, as is suggested, for example,
by the observation that 4/14 independent clones used
Va10, which was paired with Vb11 in three cases.
Table VI summarizes the estimated frequencies of all
CD1d-restricted TCR families among CD41 splenocytes
in MHC class II–deficient mice, based on all our hybrido-
mas and in vivo studies. Although a precise estimate cannot
be provided for all the families, there is an overall excellent
correlation between in vitro (hybridomas) and in vivo
(mice) studies, strengthening the conclusion that the
CD1d-restricted TCR repertoire is dominated by a few
autoreactive TCR families.
Non-Va14, CD1d-restricted T Cells Have a Natural Mem-
ory Phenotype. The above results suggested that a large frac-
tion of CD4 cells expressing a CD1d-restricted TCR are in
fact cells with overt or latent autoreactivity to CD1d.
Therefore, like Va14 T cells (9) and Va3.2/Vb8 T cells
(data not shown), the other CD1d-dependent T cells should
uniformly express a memory phenotype because of ex-
posure to self. Fig. 3 shows that a majority of the
CD41CD1d/aGalCer2 cells in MHC class II–deficient
Table V. TCR Gene Usage by Va14/Va3.2/Va82 CD1d 
Autoreactive Hybridomas
Hybridoma NK1.1 origin VaJa Vb
SPS3.10 2 Va10Ja5V b11
SPS1.21 2 Va10Ja22 ND
SPS8.23 2 Va10Ja26 Vb11
S2M7 2 Va10Ja26 Vb11
SPS8.1 2 Va15Ja21 Vb2
P4 1 Va15Ja22 Vb8.2Jb2.4
SPS3.5 2 Va2Ja2V b5
SBC12 2 Va3Ja23 Vb5.1Jb2.4
SPS9.1 2 Va4Ja48 ND
32E9.227 1 Va4V b8
S2M16 2 Va5Ja33 Vb8.2Jb1.4
S2P16 1 Va12Ja18 Vb4
DPS1.7 1 Va13Ja22 Vb9
S2P23 1 Va18Ja23 Vb8 900 The CD1d-restricted TCR Repertoire
spleens did indeed express a memory CD44hiCD122hi phe-
notype. In MHC class II/CD1d doubly deficient litter-
mates, the few tetramer-negative cells that exhibited a naive
phenotype were slightly increased, further indicating the ab-
sence of a sizable component of naive CD1d-restricted non-
Va14 T cells. In support of this conclusion, direct staining
of the CD1d-dependent Va3.2/Vb8 T cells in MHC class
II–deficient mice showed a uniform memory phenotype
(data not shown). Therefore, these results imply that most of
the CD1d-dependent T cells express the characteristic phe-
notype of memory, antigen-experienced CD4 cells.
Taken together, our results strongly support the notion
that nearly all of the non-Va14 CD1d-restricted T cells are
autoreactive, memory-type cells resembling Va14 NK T
cells. Their overall frequency is much lower than Va14
NK T cells, most likely because their CD1d reactivity is
not germline encoded, requiring several nucleotide inser-
tions in the CDR3a region to generate the appropriate
specificity, and therefore arising with lower probability.
Mainstream MHC-restricted CD8 Cells Do Not Cross-react
onto CD1d. CD8 but not CD4 can function as a corecep-
tor for CD1d (18, 35, 40). To test the possibility that MHC
molecules might select naive CD8 T cells capable of inter-
acting with CD1d, we immunized C57BL/6.CD1d2/2 fe-
male mice with C57BL/6.CD1d1/1 male spleen cells. This
dual immunization with H-Y/Db and CD1d, both of
which are highly expressed on dendritic cells and B cells, al-
lowed us to compare the magnitude of the killer response
against each of these antigens. H-Y/Db is a weak “minor”
H antigen that is recognized by a population of CD8 cells
whose frequency is very low, in the 1025 range. In contrast,
similar to allelic forms of MHC molecules, “CD1d” consists
of a high density of various CD1d/glycolipid complexes to
which the CD1d–deficient host is not tolerant. However, as
shown in Fig. 4, H-Y–specific killing was easily detected,
whereas there was 10–50-fold lower CD1d-specific killing
in several experiments. Furthermore, a significant fraction
of this weak, inconsistent response might actually have been
directed against CD1d peptides presented by MHC class I
molecules, though, given the irregular response pattern, this
possibility could not be directly tested. A similar result was
obtained when CD1d/aGalCer was used as an antigen
(data not shown). Therefore, the data support the notion
that the MHC-restricted TCR repertoire is essentially un-
able to use CD1d as a restricting element, probably because
of the divergent evolution of MHC and CD1.
Discussion
Before this study, the nature and diversity of the CD1-
restricted T cells had not been systematically explored.
However, this question has essential implications not only
for the prospects of lipid vaccination but also, more gener-
ally, for our understanding of the evolution of lipid versus
peptide antigen recognition by T cells.
Although there is evidence that CD1-restricted T cells
may recognize diverse lipid antigens in a manner similar to
Table VI. Estimated Frequencies of CD1d-restricted TCRs in 
MHC Class II–deficient CD41 Splenocytes
TCR family
In vitro studies
(hybridomas)
In vivo
(mice)
%* %*
Va14-Ja18 48 40
Va3.2-Ja94 2
Va8 .4N D
Other .4N D
Total ND 52‡
*Frequency estimates are given for whole CD41 splenocytes, including
NK1.11 and NK1.12 cells. They are based on a compilation of data
obtained from all of our in vitro studies with hybridomas and in vivo
studies of fresh splenocytes with FACS® analysis. 
‡The frequency of all CD1d-restricted CD41 T cells in vivo is deduced
from the comparison of the frequency of CD41 cells in MHC class II–
versus MHC class II/CD1d–deficient mice.
Figure 3. Memory phenotype of CD1d-restricted T cells. Panels rep-
resent the FACS® dot plots of CD4 1TCR-b1 gated spleen cells of litter-
mates of the indicated genotypes.
Figure 4. CD1d-deficient mice do not efficiently generate killer cells
against CD1d. C57BL/6.CD1d2/2 female mice were immunized with
C57BL/6 male spleen cells and killing responses against LPS blasts from
C57BL/6 males (H-Y 1 CD1), C57BL/6.CD1d2/2 males (H-Y), C57BL/6
females (CD1), and C57BL/6.CD1d2/2 females (none) were measured in
vitro. Each graph represents separate experiments with three mice each.901 Park et al.
MHC-restricted adaptive recognition of peptide antigens
by mainstream ab T cells (3, 41), relatively few examples
of CD1-restricted antigen-specific responses have been re-
ported so far. On the other hand, and in contrast to MHC-
restricted T cells, prominent subsets of CD1-restricted T
cells expressing semiinvariant autoreactive TCRs have
been identified, prompting the interesting suggestion that
CD1 primarily evolved to survey self-lipid antigens in dif-
ferent intracellular compartments, only recently acquiring
or being coopted for the ability to present microbial lipids
to T cells (42).
We focused our study on CD1d, the only isotype ex-
pressed in the mouse. In addition to the conserved CD1d
autoreactive population of mouse Va14/human Va24 NK
T cells, the existence of other CD1d-restricted T cells, pos-
sibly associated with the adaptive rather than the innate arm
of immunity, had been inferred from reports of non-Va14
CD1d-restricted T cells (17, 22, 23) and from immuniza-
tion experiments suggesting that CD1d-restricted CD8 T
cell–mediated killing responses against peptide antigens
could be elicited in vivo (18, 37).
To estimate the size and diversity of the non-Va14
CD1d-restricted TCR repertoire and to determine the fre-
quency and phenotype of the corresponding T cells, we
performed in vivo studies of MHC-deficient and MHC/
CD1d doubly deficient mice using CD1d/aGalCer tet-
ramers to identify the Va14 T cells and zoom in on the
non-Va14–based CD1d-restricted population, combined
with in vitro analysis of large panels of non–MHC-
restricted hybridomas. The striking conclusion emerging
from our studies was that, in sharp contrast with MHC class
I– or class II–restricted T cells, the TCR repertoire of
CD1d-restricted T cells is dominated by a restricted set of
ab TCRs. In addition to the Va14 TCR, we found that
some of the “diverse” TCRs previously identified in vitro
were actually recurrently used, a finding that escaped rec-
ognition because of the limited size of the hybridoma pan-
els examined. The most prominent of the non-Va14 TCR
families, Va3.2-Ja9/Vb8 and Va8/Vb8, were expressed
by a sufficient number of independent clones that an in
depth analysis was possible. This revealed that, unlike the
canonical Va14-Ja18, these TCRs were not germline en-
coded, a finding that is sufficient to explain why they
would arise at a much lower frequency than the Va14
TCRs during the random V-J recombination process. Par-
ticularly revealing was the study of the Va3.2-Ja9 se-
quences, which disclosed that at least three nucleotide sub-
stitutions were required to generate a canonical motif,
including arginine/lysine 94 and glycine 95. Despite their
very low frequency (z20 times less than Va14 T cells), we
were able to visualize the Va3.2/Vb8 cells in vivo by
TCR-a and -b staining of the residual CD41TCR-b1
cells in MHC class II–deficient mice, and demonstrate their
dependence on CD1d by examining MHC class II/CD1
doubly deficient mice.
Interestingly, like the Va14-Ja18 T cells themselves, the
non-Va14 CD1d-dependent T cell hybrids were often au-
toreactive, responding to CD1d-expressing thymocytes,
splenocytes, and transfected CD1d1 lines. Like the Va14-
Ja18 sequences, the Va3.2-Ja9 segments clearly exhibited
signs of antigen-driven selection, suggesting in vivo selec-
tion by self-antigen. Unlike the Va14 population, how-
ever, the non-Va14 T cells do not respond to the surrogate
antigen aGalCer (28, 43). Their pattern of autoreactivity
also differs from Va14 T cells in that we previously showed
they do not require endosomal targeting by the tyrosine-
based endosomal targeting motif of CD1d to respond to
their self-ligand (23). Altogether, these data indicate that,
unlike the MHC-restricted TCR repertoire, the CD1d-
restricted TCR repertoire is dominated by a limited range of
specificities for distinct self-antigens rather than by a large
set of specificities for a diverse universe of foreign antigens.
Our results do not exclude the existence of a functional
diverse and naive “adaptive” CD1d-restricted TCR, but
they suggest that it must be very limited in size compared
with the autoreactive innate repertoire. An inherent limita-
tion in our studies is that we could not directly visualize the
CD1d-restricted T cells, but rather we inferred their fre-
quencies from a comparison between MHC and MHC/
CD1d doubly deficient mice. Thus, it is possible that a
population of naive and diverse CD1d-restricted T cells
might go undetected because it somehow requires the pres-
ence of MHC or MHC-restricted T cells. This is unlikely
because, first, cell populations tend to expand rather than
contract where space is available and second, the absolute
numbers of Va14-Ja18 and Va3.2/Vb8 CD1d-restricted
T cells, which could be directly measured using flow cy-
tometry, remained remarkably constant in the absence of
MHC (data not shown). Another limitation of the study is
that we could not ascribe a restriction element to up to
55% of the NK1.12 CD4 T cell hybridomas, because either
they failed to exhibit CD1d autoreactivity or they did not
express a canonical Va14 or Va3.2 TCR (Table I). It is
possible that they include a proportion of CD1d-restricted
T cells with diverse TCRs. However, this population
would still be numerically inferior to the combined
NK1.11 and NK1.12 CD1d autoreactive T cells. In addi-
tion, it must include the residual MHC class II/CD1d–inde-
pendent CD4 T cells found in vivo.
The phenotype of the CD1d-restricted T cells is consis-
tent with the view that they predominantly express autore-
active TCRs. They do not exhibit a naive phenotype like
the majority of MHC-restricted T cells but almost exclu-
sively express high surface levels of several of the molecules
associated with memory/effector cells, such as CD44 and
IL-2Rb. In addition, a significant fraction of them express
NK receptors such as NK1.1, though the frequency of ex-
pression may depend on individual TCR families. Finally,
they uniformly lack the expression of CD8, which was pre-
viously shown to induce negative selection of Va14 au-
toreactive T cells, but rather express CD4 (35, 36). Thus,
our study implies that (a) a majority of CD1d-dependent
ab T cells express an autoreactive TCR and a “natural
memory” NKT phenotype, (b) a single germline encoded
TCR family, Va14-Ja18/Vb8, Vb7, Vb2, is the main
partner of CD1d, at least in the mouse, and (c) other natu-902 The CD1d-restricted TCR Repertoire
ral examples of CD1d autoreactive ab TCRs exist but they
are less frequent, not germline encoded, and recurrent.
Although our results may seem to conflict with previous
suggestions of a diverse CD1d-restricted TCR repertoire, a
reanalysis of the published reports in the context of our
data permits a resolution of some apparent contradictions.
For example, it seems clear that other studies of T cell hy-
bridomas and clones missed sighting the recurrent, antigen-
driven non-Va14 TCRs because the numbers of indepen-
dent clones analyzed were small, inferior to five in each study.
Conversely, in support of the view that CD1d-restricted T
cells recognize a limited set of (mostly self) antigens, there
are several indications that few exogenous antigens can be
recognized in the context of CD1d. For example, myco-
bacterial lipoarabinomannan, an abundant mycobacterial
product that can be recognized by human CD1b-restricted
T cells (44) and also binds strongly to CD1d (28), failed to
induce a CD1d-restricted T cell response in mice despite
repeated immunizations (45). Furthermore, CD1d-defi-
cient mice normally clear M. tuberculosis whether injected
intravenously or inhaled (46, 47). Likewise, immunization
with a hydrophobic peptide carrying a CD1d binding mo-
tif (defined by screening of a peptide phage display library)
elicited only a weak CD8 T cell response, even after strong
priming by a simultaneous injection of different plasmids
encoding CD1d, peptide, and B7. Attempts to derive in
vitro lines or clones of these putative peptide-specific
CD1d-restricted T cells were unsuccessful, preventing a
full characterization of the responding T cells (18, 37, 40).
Perhaps not surprisingly in light of our study, efforts by
other investigators to obtain such cell lines specific for for-
eign peptides resulted instead in the generation of CD1d
autoreactive clones expressing Va14 and non-Va14 TCRs
(17). The inherently autoreactive nature of many non-
Va14 CD1d-restricted T cells is also highlighted by two
independent reports that transgenic strains expressing non-
Va14 CD1d-restricted TCRs exhibited either overt au-
toreactivity and systemic lupus erythematosus in one case
(48), or in the other case, the same memory/NKT pheno-
type as the Va14 T cell subset (49). Finally, there is also
good evidence from MHC-restricted TCR transgenic ex-
periments that the DN NK1.11 phenotype is often associ-
ated with autoreactivity (7, 8).
Altogether, the results demonstrate a striking general bias
of the naturally selected CD1d-restricted T cell population
towards autoreactivity, explaining the natural memory
phenotype and perhaps also the expression of inhibitory
NK receptors to regulate it. This bias is contributed by a
very restricted TCR a chain usage, which is often invari-
ant, and a more promiscuous but still somewhat limited use
of Vb families, characteristically including Vb8 with di-
verse VDJ junctions. Furthermore, the evolutionary diver-
gence between CD1 and MHC molecules, which share
only 30% identity, precludes the usage of MHC-restricted
TCRs to take advantage of lipid presentation by CD1d be-
cause, as we showed, these TCRs do not cross-react onto
CD1d molecules. Thus, we conclude that the population
of ab T cells available to recognize potential lipid antigens
presented by CD1d is largely restricted to the natural mem-
ory/autoreactive NKT cell subset and its limited TCR rep-
ertoire. Our conclusion applies to the mouse CD1d system
and cannot be extrapolated to other CD1 isotypes or to
human CD1d. Further studies should clarify the extent to
which these other CD1 isotypes may have taken up a more
recent evolutionary function of presenting a variety of lipid
antigens to the adaptive arm of the immune system.
There are striking resemblances between the CD1d-
restricted T cell population, as defined in this study and B-1
B cells, marginal zone B cells, and gd T cells. Like CD1d-
restricted T cells, B-1 cells, marginal zone B cells, and gd T
cells are largely composed of antigen-driven autoreactive
subsets expressing different types of semiinvariant germ-
line-encoded antigen receptors with “supertypic” specifici-
ties for antigen families, and transgenic experiments have
shown that, as for Va14 T cells, the specificity of the anti-
gen receptor drives a developmental program leading to ac-
quisition of their peculiar differentiation and tissue distribu-
tion (12, 50–54). Collectively, these studies delineate a
family of lymphocytes expressing rearranged but germline-
encoded self-antigen–reactive receptors that are present at
relatively high frequencies and contribute to innate immu-
nity. Their self-reactivity is somewhat difficult to compre-
hend within the context of the classical self/nonself dis-
crimination model of tolerance, and in that regard, it is
interesting that they usually prevent rather than aggravate
chronic autoimmune conditions (15). It is increasingly en-
visioned that these innate cells may function as sentinels de-
tecting modified self in conditions of tissue stress and dam-
age (55) and act as regulators of the cytokine, chemokine,
and costimulatory environment governing adaptive im-
mune response. These innate lymphocytes are closer to NK
cells, together with which they represent up to 20–50% of
the lymphocyte population both in lymphoid organs and in
tissues, than to classic adaptive B and T cells. Thus, they
may not participate in memory formation to a diverse
range of foreign antigens or be targets of conventional vac-
cine schemes.
Another important implication of this study is that there
seem to exist systematic differences between MHC-driven
and CD1d-driven T cell selection processes. What are the
cause and the mechanisms underlying the peculiar develop-
ment and differentiation of a majority of CD1d-restricted
T cells and preventing the emergence of a naive, diverse
CD1d-restricted population? One possibility is that only a
few TCR-a genes have been evolutionarily selected to
recognize CD1d, in comparison with those selected to rec-
ognize MHC products (56). In this scenario, given the lack
of cross-reactivity of the MHC-restricted TCRs, the cells
expressing these CD1d-specific genes would dominate the
CD1d-restricted population, especially if they are autoreac-
tive and strongly selected by chronic exposure to self-anti-
gen. Another intriguing, nonexclusive possibility is that
interaction with the cortical thymocyte, the CD1d-
expressing cell type required for the selection of NKT cells
(57), may not provide the same range of signals that special-
ized thymic epithelial cells provide for the selection of903 Park et al.
MHC-restricted low avidity T cells (58). In this scenario,
only thymocytes expressing TCRs with high avidity for
CD1d ligands would be selected. These T cells would
achieve regulation of their autoreactive properties through
the expression of inhibitory NK receptors. It is intriguing
to speculate that such modes of selection might represent a
primordial mechanism governing the selection and mainte-
nance of the innate, preadaptive repertoire of T cells.
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